Circ J. 2022 Dec 28. doi: 10.1253/circj.CJ-22-0652.
The Prognostic Value of B-Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE-CS.
Miyakuni S, Maeda D, Matsue Y, Yoshioka K, Dotare T, Sunayama T, Nabeta T, Naruse Y, Kitai T, Taniguchi T, Tanaka H, Okumura T, Baba Y, Matsumura A, Minamino T.
J Am Heart Assoc. 2022 Dec 20;11(24):e025803.
Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis.
Kitai T, Nabeta T, Naruse Y, Taniguchi T, Yoshioka K, Miyakoshi C, Kurashima S, Miyoshi Y, Tanaka H, Okumura T, Baba Y, Furukawa Y, Matsue Y, Izumi C.
Heart. 2022 Nov 10;108(23):1887-1894.
Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry.
Tamura Y, Tamura Y, Taniguchi Y, Tsujino I, Inami T, Matsubara H, Shigeta A, Sugiyama Y, Adachi S, Abe K, Baba Y, Hatano M, Ikeda S, Kusunose K, Sugimura K, Usui S, Takeishi Y, Dohi K, Hasegawa-Tamba S, Horimoto K, Kikuchi N, Kumamaru H, Tatsumi K; Japan Pulmonary Hypertension Registry Network.
Circ Rep. 2022 Oct 8;4(11):542-549.
Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
ESC Heart Fail. 2022 Oct 3. doi: 10.1002/ehf2.14163.
Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
Nabeta T, Kitai T, Naruse Y, Taniguchi T, Yoshioka K, Tanaka H, Okumura T, Sato S, Baba Y, Kida K, Tamaki Y, Matsumoto S, Matsue Y.
Eur Heart J. 2022 Sep 21;43(36):3450-3459.
Acute Left Circumflex Coronary Artery Occlusion - Diagnostic Problems of Initial
Komatsu J, Nishimura YK, Sugane H, Hosoda H, Imai RI, Nakaoka Y, Nishida K, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.
Incidence and Clinical Characteristics of Takotsubo Syndrome in Patients with Subarachnoid Hemorrhage.
Fujita T, Nakaoka Y, Hayashi S, Imai RI, Nishida K, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.
Int Heart J 63; 517-523, 2022.
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.
Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP.
Eur J Prev Cardiol 29; 645-653, 2022.
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
Protonotarios A, Bariani R, Cappelletto C, Pavlou M, García-García A, Cipriani A, Protonotarios I, Rivas A, Wittenberg R, Graziosi M, Xylouri Z, Larrañaga-Moreira JM, de Luca A, Celeghin R, Pilichou K, Bakalakos A, Lopes LR, Savvatis K, Stolfo D, Dal Ferro M, Merlo M, Basso C, Freire JL, Rodriguez-Palomares JF, Kubo T, Ripoll-Vera T, Barriales-Villa R, Antoniades L, Mogensen J, Garcia-Pavia P, Wahbi K, Biagini E, Anastasakis A, Tsatsopoulou A, Zorio E, Gimeno JR, Garcia-Pinilla JM, Syrris P, Sinagra G, Bauce B, Elliott PM.
Eur Heart J 43; 3053-3067, 2022.
Assisted living and medication adherence in super-aged patients with heart failure in the Japanese population.
Kawada K, Kubo T, Ishida T, Jobu K, Morisawa S, Hamada T, Baba Y, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Fukuda H, Ohta T, Hayashi T, Kitaoka H, Miyamura M.
J Cardiovasc Pharmacol 79; 467-471, 2022.
A Drifting Dislodged Leadless Pacemaker in the Bilateral Pulmonary Arteries.
Sugiura K, Baba Y, Hirota T, Kubo T, Kitaoka H.
JACC Case Rep 4: 844-846, 2022.
Very long-term prognosis in patients with hypertrophic cardiomyopathy: a longitudinal study with a period of 20 years.
Sugiura K, Kubo T, Ochi Y, Miyagawa K, Baba Y, Noguchi T, Hirota T, Yamasaki N, Doi YL,Kitaoka H.
ESC Heart Fail 9; 2618-2625, 2022.
Clinical Features of Heart Failure in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.
Miyamoto Y, Kubo T, Ochi Y, Baba Y, Hirota T, Yamasaki N, Kawai K, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.
Circ J 86; 1939-1940, 2022.
Early Experience of Tafamidis Treatment in Japanese Patients With Wild-Type Transthyretin Cardiac Amyloidosis From the Kochi Amyloidosis Cohort.
Ochi Y, Kubo T, Baba Y, Sugiura K, Miyagawa K, Noguchi T, Hirota T, Hamada T, Yamasaki N, Kitaoka H.
Circ J 86; 1121-1128, 2022.
Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
ESC Heart Fail 9; 1853-1863, 2022.
A retrospective investigation to establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients.
Kubo T, Amano M, Takashio S, Okumura T, Yamamoto S, Nabeta T, Oikawa M, Kurisu S, Ochi Y, Sugiura K, Baba Y, Kuroiwa H, Hirota T, Yamasaki N, Ishii S, Nochioka K, Takeishi Y, Yasuda S, Tsujita K, Izumi C, Kitaoka H.
J Cardiol 80; 325-331, 2022.
Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.
Norrish G, Ding T, Field E, Cervi E, Ziółkowska L, Olivotto I, Khraiche D, Limongelli G, Anastasakis A, Weintraub R, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Marrone C, Bökenkamp R, Baban A, Kubus P, Daubeney PEF, Sarquella-Brugada G, Cesar S, Klaassen S, Ojala TH, Bhole V, Medrano C, Uzun O, Brown E, Gran F, Sinagra G, Castro FJ, Stuart G, Vignati G, Yamazawa H, Barriales-Villa R, Garcia-Guereta L, Adwani S, Linter K, Bharucha T, Garcia-Pavia P, Siles A, Rasmussen TB, Calcagnino M, Jones CB, De Wilde H, Kubo T, Felice T, Popoiu A, Mogensen J, Mathur S, Centeno F, Reinhardt Z, Schouvey S, O'Mahony C, Omar RZ, Elliott PM, Kaski JP.
Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
ESC Heart Fail. 2022 Mar 30.
99m Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.
Tahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee HE, Russo E, Kubo T
ESC Heart Fail 9; 251-262, 2022.
2021年
Assisted Living and Medication Adherence in Super-Aged Patients With Heart Failure in the Japanese population.
Kawada K, Kubo T, Ishida T, Jobu K, Morisawa S, Hamada T, Baba Y, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Fukuda H, Ohta T, Hayashi T, Kitaoka H, Miyamura M.
J Cardiovasc Pharmacol. 2021 Dec 27.
Association between acute coronary syndrome onset risk and climate change.
Aoyagi T, Chiba Y, Kitaoka H.
Arch Environ Occup Health. 2021 Dec 15:1-10.
Early cardiac rehabilitation for acute decompensated heart failure safely improves physical function (PEARL study): a randomized controlled trial.
Nakaya Y, Akamatsu M, Ogimoto A, Kitaoka H.
Eur J Phys Rehabil Med. 2021 Dec;57(6):985-993.
Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
Kubo T, Baba Y, Ochi Y, Hirota T, Yamasaki N, Kawai K, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.
ESC Heart Fail. 2021 Dec;8(6):5022-5030.
Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis - Reply.
Ochi Y, Kubo T, Baba Y, Yamasaki N, Kitaoka H.
Circ Rep. 2021 Nov 11;3(12):749-750.
The High Road or the Low Road? A Question Regarding Whether to Use Upper or Lower Pulmonary Veins in Measuring Pulmonary Vein Flow.
Baba Y, Kubo T, Kitaoka H.
J Am Soc Echocardiogr. 2021 Oct;34(10):1116-1117.
Progressive deterioration of frailty is associated with poor outcomes in patients with transthyretin cardiac amyloidosis.
Takahashi M, Okamoto N, Nishida K, Nakaoka Y, Imai RI, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.
Geriatr Gerontol Int. 2021 Oct;21(10):967-969.
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies.
Kitaoka H, Tsutsui H, Kubo T, Ide T, Chikamori T, Fukuda K, Fujino N, Higo T, Isobe M, Kamiya C, Kato S, Kihara Y, Kinugawa K, Kinugawa S, Kogaki S, Komuro I, Hagiwara N, Ono M, Maekawa Y, Makita S, Matsui Y, Matsushima S, Sakata Y, Sawa Y, Shimizu W, Teraoka K, Tsuchihashi-Makaya M, Ishibashi-Ueda H, Watanabe M, Yoshimura M, Fukusima A, Hida S, Hikoso S, Imamura T, Ishida H, Kawai M, Kitagawa T, Kohno T, Kurisu S, Nagata Y, Nakamura M, Morita H, Takano H, Shiga T, Takei Y, Yuasa S, Yamamoto T, Watanabe T, Akasaka T, Doi Y, Kimura T, Kitakaze M, Kosuge M, Takayama M, Tomoike H
Japanese Circulation Society Joint Working Group.Circ J. 2021 Aug 25;85(9):1590-1689.
Frailty in patients with acute decompensated heart failure in a super-aged regional Japanese cohort.
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
ESC Heart Fail. 2021 Aug;8(4):2876-2888.
Wild-Type Transthyretin Amyloidosis in Female Patients - Consideration of Sex Differences.
Ochi Y, Kubo T, Baba Y, Sugiura K, Ueda M, Miyagawa K, Noguchi T, Hirota T, Hamada T, Yamasaki N, Kitaoka H.
Circ Rep. 2021 Jun 29;3(8):465-471
What is low cardiac output syndrome? A report of two cases
Baba Y, Kubo T, Ochi Y, Noguchi T, Yamasaki N, Kitaoka H
Crit Care Shock (2021) 24:135-142
Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release.
Sugiura K, Kozuki H, Ueba H, Kubo T, Ochi Y, Baba Y, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Wada N, Nakashima J, Murakami I, Ikeuchi M, Kitaoka H.
Circ Rep. 2021 May 27;3(6):338-344.
Association between self-reported night sleep duration and cognitive function among older adults with intact global cognition.
Kondo R, Miyano I, Lee S, Shimada H, Kitaoka H.
Int J Geriatr Psychiatry. 2021 May;36(5):766-774.
A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic Cardiomyopathy.
Ochi Y, Kubo T, Baba Y, Ueda M, Hirota T, Yamasaki N, Kitaoka H.
CASE (Phila). 2021 Apr 8;5(3):160-165.
Added value of anxiolytic benzodiazepines in predictive models on severe delirium in patients with acute decompensated heart failure: A retrospective analysis.
Kawada K, Fukuda H, Kubo T, Ohta T, Ishida T, Morisawa S, Kawazoe T, Okamoto M, Fujita H, Jobu K, Morita Y, Ueba T, Kitaoka H, Miyamura M.
PLoS One. 2021 Apr 22;16(4):e0250372.
A Validation Study of the Mayo Clinic Phenotype-Based Genetic Test Prediction Score for Japanese Patients With Hypertrophic Cardiomyopathy.
Moriki T, Kubo T, Sugiura K, Ochi Y, Baba Y, Hirota T, Yamasaki N, Kimura A, Doi YL, Kitaoka H.
Circ J. 2021 Apr 23;85(5):669-674.
Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.
Ochi Y, Kubo T, Baba Y, Ueda M, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H
J Cardiol 77; 124-130, 2021
What we believed to be a right upper pulmonary vein by transthoracic echocardiography is actually a right lower pulmonary vein.
Baba Y, Ochi Y, Hirota T, Arima N, Sugiura K, Kawaguchi J, Hirakawa D, Kubo T, Yamasaki N, Kitaoka H:
Echocardiography 38; 427-434, 2021.
The dawn of precision medicine in cardiomyopathies Advance preparations of ethnicity-specific database
Kubo T, Morita H
Circ J 85; 1479-1480, 2021.
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.
Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP
mTOR-mediated calcium transients affect cardiac function in ex vivo ischemia-reperfusion injury.
Shimada BK, Yorichika N, Higa JK, Baba Y, Kobayashi M, Aoyagi T, Suhara T, Matsui T.
Physiol Rep. 2021 Mar;9(6):e14807
2020年
Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I.
Sugiura K, Kubo T, Ochi Y, Baba Y, Hirota T, Yamasaki N, Kitaoka H.
Mol Genet Metab Rep. 2020 Oct 20;25:100662.
Elevation of high-sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy.
Kubo T, Ochi Y, Baba Y, Sugiura K, Takahashi A, Hirota T, Yamanaka S, Yamasaki N, Doi YL, Kitaoka H.
ESC Heart Fail. 2020 Oct 12;7(6):3593-600.
The diaphragm affects echocardiographic measurement of inferior vena cava diameter to predict right atrial pressure.
Baba Y, Kawaguchi J, Ochi Y, Hirakawa D, Oryu T, Noguchi T, Hirota T, Kubo T, Yamasaki N, Kitaoka H.
J Med Ultrason (2001). 2020 Oct;47(4):565-573.
Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
Nakashima Y, Kubo T, Sugiura K, Ochi Y, Takahashi A, Baba Y, Hirota T, Yamasaki N, Kimura A, Doi YL, Kitaoka H.
Circ J. 2020 Sep 25;84(10):1846-1853.
Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.
Kubo T, Baba Y, Ochi Y, Takahashi A, Hirota T, Yamasaki N, Hamashige N, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.
Circ Rep. 2020 Jul 2;2(8):433-439.
Preoperative Clinical Features and High Pulmonary Wedge Pressure with a Discordant Pattern as Prognostic Factor in Hemodialysis Patients with Severe Aortic Valve Stenosis.
Ueda M, Kubo T, Ochi Y, Takahashi A, Miyagawa K, Baba Y, Noguchi T, Hirota T, Yamasaki N, Yamamoto M, Nishimori H, Sasaguri S, Orihashi K, Kitaoka H.
Int Heart J. 2020 Jul 30;61(4):720-726.
Hypertrophic Cardiomyopathy - A Heterogeneous and Lifelong Disease in the Real World.
Kitaoka H, Kubo T, Doi YL.
Circ J. 2020 Jul 22;84(8):1218-1226.
Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese Outpatients.
Kawada Y, Kubo T, Baba Y, Hirota T, Tanioka K, Yamasaki N, Kitaoka H.
Acta Med Okayama. 2020 Apr;74(2):103-108.
Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis.
Ochi Y, Kubo T, Baba Y, Nakashima Y, Ueda M, Takahashi A, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H.
Circ Rep. 2020 Apr 29;2(6):314-321.
Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis.
Okamoto N, Kubo T, Nakashima Y, Ochi Y, Takahashi A, Baba Y, Hirota T, Yamasaki N, Kitaoka H.
Intern Med. 2020 Feb 1;59(3):339-343.
Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy.
Ochi Y, Kubo T, Nakashima Y, Baba Y, Hirota T, Yamasaki N, Yamashita T, Ueda M, Ando Y, Kitaoka H.
A case reprt of asymmetry of systolic anterior motion of the mitral vlave, a not widely well-known but practically iportant echocardiographoic presentaton in hypertrophic cardiomyopathy.
Ochi Y, Kubo T, Baba Y, Ueda M, Hirota T, Yamasaki N, Kitaoka H.
CASE (Phila) 5: 160-165, 2021. (IF 5.251)
学会発表
2023年
2022年
超高齢者(oldest-old)入院患者における リスクスコアを加味した抗血栓療法の考察
宮川和也
第64回日本老年医学会学術集会
Prevalence and clinical impact of cardiorenal anemia syndrome in older patients with acute heart failure.
濵田知幸
第26回日本心不全学会学術集会
高齢急性心不全患者におけるフレイル重積の退院1年以内の予後への影響
濵田知幸
第64回日本老年医学会学術集会
Prognostic Impact of Frailty Status Based on the Kihon Checklist in Patients With Acute Decompensated Heart Failure
濵田知幸
第86回日本循環器学会学術集会
Additional Prognostic Value of Frailty Assessment to the Get With the Guideline-Heart Failure Risk Score in Patients With Acute Decompensated Heart Failure
濵田知幸
第86回日本循環器学会学術集会
Hydrophilic polymer emboli in patients with critical limb ischemia: a review of four cases leading to critical outcomes
宮本雄也
第30回日本心血管インターベンション治療学会
What are the Characteristics of Lesions with Target Lesion Failure at Follow-up Coronary Angiography after Percutaneous Coronary Intervention?
Drug treatment for obstructive hypertrophic cardiomyopathy
久保亨, 杉浦健太. 山崎直仁,北岡裕章
第86回日本循環器学会学術集会
Prognostic Impact of Frailty Status Based on the Kihon Checklist in Patients With Acute Decompensated Heart Failure
濵田知幸,久保亨,中岡洋子,川井和哉,矢部敏和,桑原昌則,古野貴志,山田英介,山崎直仁,北岡裕章
第86回日本循環器学会学術集会
Additional Prognostic Value of Frailty Assessment to the Get With the Guideline-Heart Failure Risk Score in Patients With Acute Decompensated Heart Failure
濵田知幸,久保亨,中岡洋子,川井和哉,矢部敏和,桑原昌則,古野貴志,山田英介,山崎直仁,北岡裕章
第86回日本循環器学会学術集会
Induction of Autoimmune Myocarditis by CTLs Specific for Cardiac Myosin Heavy Chain-Alpha
